A Multi-centre Observational Study to Describe Usage and Dosification Patterns of RoActemra (Tocilizumab) Treatment in Rheumatoid Arthritis (RA) Patients in the Routine Clinical Practice. ACT-LIFE Study.
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms ACT-LIFE
- Sponsors Roche
- 23 May 2013 Actual initiation date changed from Nov 2012 to Aug 2012 as reported by ClinicalTrials.gov.
- 23 May 2013 Actual initiation date changed from Aug 2010 to Jul 2010 as reported by ClinicalTrials.gov.
- 06 Jul 2012 Actual patient number 400 added as reported by ClinicalTrials.gov.